Heart Disease Clinical Trials in Tennessee

Showing 241-260 of 499 trials

The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease

NCT04828590

DEEPVESSEL FFR is a medical device that is designed to extract three- dimensional coronary tree structures and generate computed tomography-derived fraction flow reserve (FFR) values from coronary CT angiogram images. The primary objective of this multi-center clinical validation study is to validate the clinical performance of DEEPVESSEL FFR in identifying patients with myocardial ischemia due to significant obstructive coronary artery diseases.

Coronary Artery DiseaseMyocardial Ischemia

Keya Medical302 participantsStarted Aug 2020

Fort Lauderdale, Florida, United States • Kansas City, Kansas, United States • Portland, Oregon, United States +7 more locations

COMPLETED29 miles

The Product Surveillance Registry REVERSE Post Approval Study

NCT01660035

The purpose of the REVERSE Post Approval Study (PAS) is to confirm the benefit observed in the REVERSE and RAFT pivotal studies in "real-world" clinical practice.

Heart Failure

Medtronic155 participantsStarted Apr 2012

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Chandler, Arizona, United States +120 more locations

The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease

The Product Surveillance Registry REVERSE Post Approval Study

Heart Disease Trials in Other Cities

Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

SUSTAIN-IT: Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support?

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management

Physiologic Assessment of Coronary Stenosis Following PCI

COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT

Clinical Outcomes in Patients Treated With SternaLock Blu

Restore EF Observational Study

Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System

Randomized Endo-Vein Graft Prospective

A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear)

Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult Centered Care

Imaging of Coronary Plaques in Participants Treated With Evolocumab

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion

A Study of CK-1827452 Infusion in Stable Heart Failure

Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements

Other Conditions in Tennessee